BaroPace Receives Approval for First-in-Human Clinical Trial

Health and Beauty1miscellaneous news
By:
On:

SAMMAMISH, Wash. — BaroPace, Inc., a medical technology company dedicated to using blood pressure to regulate pacemakers for patients with heart failure with preserved ejection fraction and hypertension, announced today that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) of India to conduct its clinical trialContinue Reading

Accutar Biotechnology Announces First Patient Dosed in China with AC0176 in Phase 1 Study in Prostate Cancer

miscellaneous news
By:
On:

CRANBURY, N.J. & SHANGHAI — Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, announces the dosing of the first patient in China in a Phase 1 study of AC0176, an orally bioavailable chimeric degrader molecule designed to target Androgen Receptor (AR) protein withContinue Reading